Tim Watts, CFO at Shield Therapeutics #STX presenting at our Life Sciences Investor Briefing Watch Now
Monday, 23rd April 2018 08:19 - by Moosh
Asiamet Resources (ARS) I increased my holding in ARS by 10% following initial drilling results from the Beutong project. New and existing investors would also be wise to view the recent interview with Peter Bird with Proactive Investors.
Empyrean Energy (EME)
I increased my holding in EME by 21% following the successful flow of gas from the Dempsey well in the latest zone to be tested.
Horizonte Minerals (HZM)
There has been no change to my holding of HZM.
The Writer's views are their own, not a representation of London South East's. No advice is inferred or given. If you require financial advice, please seek an Independent Financial Adviser.